This article is more than 5 years old. Information may no longer be current.

Oculus receives 510(k) clearance for Pentacam AXL

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.

The device, which combines anterior segment tomography and optical biometry for premium IOL calculation, integrates standard IOL formulas and ray-tracing formulas. Toric IOL calculation is based on total corneal refractive power and factors in the posterior corneal surface, the release said.

The Pentacam AXL also integrates a comprehensive IOL database with IOL constants, the release said.

The device features a fast screening report, Belin/Ambrósio enhanced ectasia display for early detection of corneal ectasia and densitometric evaluation.